Literature DB >> 4011070

Comparison of bone density in amenorrheic women due to athletics, weight loss, and premature menopause.

K P Jones, V A Ravnikar, D Tulchinsky, I Schiff.   

Abstract

Studied was the peripheral bone density of 39 women (ages 18 to 43) with the diagnosis of secondary amenorrhea in an effort to define the population of amenorrheic women at risk for osteoporosis. Eight women had exercise-induced amenorrhea (athletes), 20 women had amenorrhea associated with weight loss, and 11 women had premature menopause. These diagnoses were made on the basis of history, physical examination, and luteinizing hormone (LH), follicle-stimulating hormone (FSH), and prolactin levels, and failure to have withdrawal bleeding after the administration of progestin. Twenty-five nonathletic, normally menstruating women served as control subjects. The peripheral bone density of the amenorrheic athletes (0.738 g/cm2 +/- 0.047) was not significantly different from that of the controls (0.726 g/cm2 +/- 0.044). The average bone density of the group with weight loss-associated amenorrhea (0.672 g/cm2 +/- 0.066) was significantly less than controls (P less than .005) as was that of the women with premature menopause (0.616 g/cm2 +/- 0.048, P less than .001). There was a significant correlation between months of amenorrhea and decrease in bone density (r = 0.506, P less than .001). From this study it was concluded that women with exercise-associated amenorrhea are not at significant risk for cortical bone loss as measured by direct photon absorptiometry. Women with weight loss-associated amenorrhea and women with premature menopause are at significant risk for bone loss when compared with normal controls.

Entities:  

Mesh:

Year:  1985        PMID: 4011070

Source DB:  PubMed          Journal:  Obstet Gynecol        ISSN: 0029-7844            Impact factor:   7.661


  12 in total

Review 1.  Bone mineral density levels in elite female athletes.

Authors:  R L Wolman
Journal:  Ann Rheum Dis       Date:  1990-12       Impact factor: 19.103

2.  Different training patterns and bone mineral density of the femoral shaft in elite, female athletes.

Authors:  R L Wolman; L Faulmann; P Clark; R Hesp; M G Harries
Journal:  Ann Rheum Dis       Date:  1991-07       Impact factor: 19.103

Review 3.  Body composition and menstrual function in athletes.

Authors:  W E Sinning; K D Little
Journal:  Sports Med       Date:  1987 Jan-Feb       Impact factor: 11.136

Review 4.  Estrogen status and bone mass in the premenopausal period: is osteoporosis a developmental disease?

Authors:  R Civitelli; D T Villareal; R Armamento-Villareal
Journal:  J Endocrinol Invest       Date:  1993-11       Impact factor: 4.256

Review 5.  Clinical consequences of athletic amenorrhoea.

Authors:  N W Constantini
Journal:  Sports Med       Date:  1994-04       Impact factor: 11.136

Review 6.  The effects of weight loss approaches on bone mineral density in adults: a systematic review and meta-analysis of randomized controlled trials.

Authors:  S Soltani; G R Hunter; A Kazemi; S Shab-Bidar
Journal:  Osteoporos Int       Date:  2016-05-06       Impact factor: 4.507

7.  Acylated ghrelin and leptin in adolescent athletes with amenorrhea, eumenorrheic athletes and controls: a cross-sectional study.

Authors:  Karla Christo; Jennalee Cord; Nara Mendes; Karen K Miller; Mark A Goldstein; Anne Klibanski; Madhusmita Misra
Journal:  Clin Endocrinol (Oxf)       Date:  2008-03-10       Impact factor: 3.478

8.  Bone metabolism in adolescent athletes with amenorrhea, athletes with eumenorrhea, and control subjects.

Authors:  Karla Christo; Rajani Prabhakaran; Brooke Lamparello; Jennalee Cord; Karen K Miller; Mark A Goldstein; Nupur Gupta; David B Herzog; Anne Klibanski; Madhusmita Misra
Journal:  Pediatrics       Date:  2008-06       Impact factor: 7.124

9.  Sacral stress fracture in a female collegiate distance runner: a case report.

Authors:  D Klossner
Journal:  J Athl Train       Date:  2000-10       Impact factor: 2.860

Review 10.  Athletic amenorrhoea. An update on aetiology, complications and management.

Authors:  R Highet
Journal:  Sports Med       Date:  1989-02       Impact factor: 11.136

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.